Cited by 355Neuroscience and Neural EngineeringRetinal Development and DisordersTactile and Sensory Interactions

The Argus® II Retinal Prosthesis System

Luo, Yvonne Hsu-Lin, da Cruz, Lyndon·2016·Progress in Retinal and Eye Research

Abstract

The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products) is the first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As such it has entered the commercial market as a treatment for patients with profound vision loss from end-stage outer retinal disease, predominantly retinitis pigmentosa. To date, over 100 devices have been implanted worldwide, representing the largest group of patients currently treated with visual prostheses. The system works by direct stimulation of the relatively preserved inner retina via epiretinal microelectrodes, thereby replacing the function of the degenerated photoreceptors. Visual information from a glasses-mounted video camera is converted to a pixelated image by an external processor, before being transmitted to the microelectrode array at the macula. Elicited retinal responses are then relayed via the normal optic nerve to the cortex for interpretation. We reviewed the animal and human studies that led to the development of the Argus(®) II device. A sufficiently robust safety profile was demonstrated in the phase I/II clinical trial of 30 patients. Improvement of function in terms of orientation and mobility, target localisation, shape and object recognition, and reading of letters and short unrehearsed words have also been shown. There remains a wide variability in the functional outcomes amongst the patients and the factors contributing to these performance differences are still unclear. Future developments in terms of both software and hardware aimed at improving visual function have been proposed. Further experience in clinical outcomes is being acquired due to increasing implantation.

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2015.09.003

Cites

182 of 182 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Argus II and PRIMA devices were designed to reduce FOV even further, thereby providing improved image resolution through a digital zoom.

    “The Argus II and PRIMA devices were designed to reduce FOV even further, thereby providing improved image resolution through a digital zoom.9,10,65”
  • Argus II can restore rudimentary vision of BVI, but the image information delivered by the implant electrodes is limited, and the high risks and high costs of invasive treatments have hindered its widespread application.

    “Argus II can restore rudimentary vision of BVI, however, the image information delivered by the implant electrodes is quite limited, the high risks and high costs of invasive treatments have also hindered its widespread application.”
  • The Argus II used 60 electrodes, leading to demonstrably higher visual acuity compared to its predecessor.

    “Its successor, the Argus II,9 used 60 electrodes, leading to demonstrably higher visual acuity21 compared to its predecessor”
  • Various RCPs have enabled blind individuals to perform simple visual tasks.

    “Various RCPs have enabled blind individuals to perform simple visual tasks.9”
  • Comparison of visual acuity with the device switched ON and OFF showed improvement only for the PRIMA and Argus II devices.

    “By this metric, comparison of visual acuity with the device switched ON and OFF showed improvement only for the PRIMA35 and Argus II9 devices.”

Cites

Flagged first, then by citations

7 of the 189 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Luo, Y. H.-L., & da Cruz, L.
Affiliations
Moorfields Eye Hospital NHS Foundation Trust (GB)
Venue
Progress in Retinal and Eye Research
Publisher
Elsevier BV
Published
2016-01
Volume
50
Pages
89-107
ISSN
1350-9462 (ISSN-L)
OpenAlex
W1778783464
Cited by
351
References
189
Citations by year
2026: 21 · 2025: 36 · 2024: 32 · 2023: 36 · 2022: 38 · 2021: 43 · 2020: 37 · 2019: 36 · 2018: 33 · 2017: 24 · 2016: 14 · 2014: 1
FWCI
2.82
Type
journal article
Language
en
Open access
closed
Locations
  • Progress in Retinal and Eye Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Tactile and Sensory Interactions
Keywords
Argus II, retinal prosthesis, retinitis pigmentosa, photoreceptor degeneration, vision loss, visual prosthesis, orientation and mobility, visual function outcomes, device safety, animal studies, clinical trials
MeSH terms
Animals, Blindness, Electrodes, Implanted, Electric Stimulation Therapy, Humans, Prosthesis Design, Retinal Diseases, Visual Acuity, Visual Perception, Visual Prosthesis, Implantable Neurostimulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review